The Proposed Drug Conditional Approval Pathway and Responses From Cancer Survivors
This survey study assesses understanding of and responses to the proposed US Food and Drug Administration conditional drug approval pathway among individuals who have received prior treatment for cancer or are currently undergoing treatment.
Authors
- Luke W. Chen
- Sharon P. Shriver (ORCID: https://orcid.org/0000-0002-7817-9296)
- Mark E. Fleury (ORCID: https://orcid.org/0000-0002-1338-6171)
- S. Long
Institutions
- American Cancer Society (US)
- Pancreatic Cancer Action Network (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.0117
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00